Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening.
BACKGROUND
Our objective was to analyse the cost effectiveness of computed tomography (CT) screening for lung cancer in terms of the cost per long-term survivor, which has not been evaluated to date.


METHODS
Estimations were computed based on data from the Surveillance, Epidemiology, and End Results registries covering years 1999-2003. The design framework of our model allowed for the incorporation of multiple values taken from the epidemiological and clinical literature to be utilised for cost inputs, scope of patients screened, diagnostic staging, and survival percentages applied separately to two cohorts: age 40-79 and 60-79 years. This enabled the analysis of over 1400 scenarios, each containing a unique set of input values, for which the estimated cost per 5-year survivor (CP5YS) was compared between the symptom-detected and proactive screening approaches.


RESULTS
Estimated CP5YS were higher for the symptom-detected approach in all 729 scenarios analysed for the cohort ages 60-79 years, ranging from approximately $5800 to $116,700 increased cost per 5-year survivor (CP5YS). For the cohort ages 40-79 years, 75% of the 729 scenarios analysed showed increased CP5YS for the symptom-detected approach ranging from $5700 to $110,000 increased CP5YS. Total costs and total 5-year survivors were higher for the proactive screening method for all scenarios analysed across both cohorts with increases ranging from 50-256% and 98-309%, respectively.


CONCLUSIONS
The predicted increase in long-term survival with CT screening and the potential for better utilisation of health-care dollars in terms of CP5YS, particularly when screening patients over the age of 60 years, are critically important considerations in directing effective future lung cancer management strategy.
Castleberry
A W
AW
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Smith
D
D
Anderson
C
C
Rotter
A J
AJ
Grannis
F W
FW
D000328:Adult; D000368:Aged; D015982:Bias; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000191:economics / Q000401:mortality*; D008875:Middle Aged; D019057:Quality-Adjusted Life Years; D017741:Survivors; D014057:Tomography, X-Ray Computed
MMWR Morb Mortal Wkly Rep. 2005 Jul 1;54(25):625-8
15988406
Int J Epidemiol. 1982 Sep;11(3):261-7
7129740
Cancer. 1999 Nov 1;86(9):1867-76
10547562
Health Serv Res. 1998 Apr;33(1):29-53
9566176
Health Care Financ Rev. 1997 Summer;18(4):51-76
10175613
J Clin Oncol. 2002 Feb 15;20(4):911-20
11844811
Chest. 1992 Apr;101(4):1013-8
1313349
J Natl Cancer Inst. 2000 Aug 16;92(16):1308-16
10944552
N Engl J Med. 2006 Oct 26;355(17):1763-71
17065637
Lung Cancer. 2003 Mar;39(3):327-30
12609571
J Natl Cancer Inst. 2006 Jun 7;98(11):724-5
16757691
Chest. 2002 May;121(5):1507-14
12006436
Chest. 2007 Jul;132(1):193-9
17505036
JAMA. 2003 Jan 15;289(3):313-22
12525232
J Clin Oncol. 2007 Jan 10;25(2):203-8
17210941
Cost Eff Resour Alloc. 2008 Feb 26;6:5
18302756
Ann Oncol. 1997 Oct;8(10):1031-9
9402178
Womens Health Issues. 1996 Sep-Oct;6(5):239-45
8870502
Chest. 2003 Aug;124(2):614-21
12907551
Eur J Cancer. 2001 Sep;37(14):1759-67
11549429
Chest. 2000 Jun;117(6):1568-71
10858384
Int J Cancer. 2008 Jun 1;122(11):2594-9
18302157
Am J Respir Crit Care Med. 2002 Feb 15;165(4):508-13
11850344
Cancer. 2003 Mar 1;97(5):1271-5
12599235
Can J Oncol. 1995 Dec;5(4):408-19
8770457
Drugs R D. 2003;4(4):243-8
12848590
Health Technol Assess. 2006 Jan;10(3):iii-iv, ix-x, 1-90
16409881
Cancer. 2001 Jul 1;92(1):153-9
11443621
Chest. 1997 Jun;111(6):1710-7
9187198
J Clin Oncol. 2004 Dec 15;22(24):4971-8
15611512
Chest. 2004 Apr;125(4):1413-23
15078754
CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30
15661684
Lancet. 1999 Jul 10;354(9173):99-105
10408484
Lung Cancer. 2001 Jun;32(3):227-36
11390004
Am J Surg Pathol. 2006 May;30(5):606-13
16699315
Med Care. 1995 Aug;33(8):828-41
7637404
JAMA. 2007 Mar 7;297(9):953-61
17341709
Lung Cancer. 2005 Apr;48(1):93-102
15777975
Oncologist. 2008 Jan;13(1):65-78
18245013
Ethn Dis. 2003 Fall;13(4):477-84
14632267